BG108161A - Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof - Google Patents

Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Info

Publication number
BG108161A
BG108161A BG108161A BG10816103A BG108161A BG 108161 A BG108161 A BG 108161A BG 108161 A BG108161 A BG 108161A BG 10816103 A BG10816103 A BG 10816103A BG 108161 A BG108161 A BG 108161A
Authority
BG
Bulgaria
Prior art keywords
medicament
derivatives
manufacture
preparation
treatment
Prior art date
Application number
BG108161A
Other languages
Bulgarian (bg)
English (en)
Inventor
Claudia Eder
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of BG108161A publication Critical patent/BG108161A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG108161A 2001-03-09 2003-09-08 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof BG108161A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105959A EP1238668A1 (en) 2001-03-09 2001-03-09 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof
PCT/EP2002/001915 WO2002072089A2 (en) 2001-03-09 2002-02-23 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
BG108161A true BG108161A (en) 2004-09-30

Family

ID=8176735

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108161A BG108161A (en) 2001-03-09 2003-09-08 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof

Country Status (24)

Country Link
US (2) US20020193418A1 (ko)
EP (2) EP1238668A1 (ko)
JP (1) JP2004521927A (ko)
KR (1) KR20040025902A (ko)
CN (1) CN1279906C (ko)
AT (1) ATE333276T1 (ko)
AU (1) AU2002250997B2 (ko)
BG (1) BG108161A (ko)
BR (1) BR0207884A (ko)
CA (1) CA2439853A1 (ko)
CZ (1) CZ20032427A3 (ko)
DE (1) DE60213219D1 (ko)
EE (1) EE200300430A (ko)
HR (1) HRP20030714A2 (ko)
IL (1) IL157792A0 (ko)
MX (1) MXPA03007551A (ko)
NO (1) NO20033964L (ko)
NZ (1) NZ528071A (ko)
PL (1) PL363374A1 (ko)
RU (1) RU2003129889A (ko)
SK (1) SK11202003A3 (ko)
WO (1) WO2002072089A2 (ko)
YU (1) YU68403A (ko)
ZA (1) ZA200306474B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108371661B (zh) * 2018-01-19 2019-03-19 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用
CN113209088B (zh) * 2021-03-11 2022-03-22 中国人民解放军军事科学院军事医学研究院 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用
CN115261422A (zh) * 2022-06-30 2022-11-01 塔里木大学 一种新物种来源硫藤黄菌素的制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032396A1 (en) * 1995-04-11 1996-10-17 John Malcolm Webster Xenorxides with antibacterial and antimycotic properties
CA2212237A1 (en) * 1997-09-05 1999-03-05 John M. Webster Novel antineoplastic agents

Also Published As

Publication number Publication date
CZ20032427A3 (cs) 2004-01-14
ZA200306474B (en) 2004-04-29
IL157792A0 (en) 2004-03-28
CA2439853A1 (en) 2002-09-19
NO20033964D0 (no) 2003-09-08
PL363374A1 (en) 2004-11-15
HRP20030714A2 (en) 2005-04-30
WO2002072089A3 (en) 2002-11-14
DE60213219D1 (de) 2006-08-31
JP2004521927A (ja) 2004-07-22
KR20040025902A (ko) 2004-03-26
WO2002072089A2 (en) 2002-09-19
EP1238668A1 (en) 2002-09-11
US20020193418A1 (en) 2002-12-19
MXPA03007551A (es) 2003-12-04
EP1372640A2 (en) 2004-01-02
BR0207884A (pt) 2004-07-27
NZ528071A (en) 2005-02-25
RU2003129889A (ru) 2005-03-10
AU2002250997B2 (en) 2006-03-09
SK11202003A3 (sk) 2004-02-03
CN1501800A (zh) 2004-06-02
CN1279906C (zh) 2006-10-18
ATE333276T1 (de) 2006-08-15
NO20033964L (no) 2003-09-08
US20050059725A1 (en) 2005-03-17
EE200300430A (et) 2003-12-15
YU68403A (sh) 2006-08-17
EP1372640B1 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
IL152073A0 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
EP1302113A4 (en) BEAUTY PRODUCTS OR PHYSIOLOGICALLY FUNCTIONAL FOODS CONTAINING SPHINGOGLYCOLIPIDS AND METHODS OF MAKING THE SAME
TW200510449A (en) Acylated nonadepsipeptides
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
BG108161A (en) Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof
RS20060263A (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
AU2002254930A1 (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
YU67203A (sh) Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
WO2003000269A3 (de) Neue verwendung für pde 10a-inhibitoren
MXPA04001951A (es) Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos.
WO2003029221A8 (de) Tetrahydroisochinoline, ihre herstellung und verwendung als schmerzmittel
MXPA04000953A (es) Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda.
MXPA04006358A (es) Derivados del drechsleranol, procedimiento para su preparacion y su utilizacion.